Lakshman, Arjun http://orcid.org/0000-0001-8915-2382
Paul, Shilpa
Rajkumar, S. Vincent
Ketterling, Rhett P.
Greipp, Patricia T.
Dispenzieri, Angela
Gertz, Morie A
Buadi, Francis K.
Lacy, Martha Q.
Dingli, David
Fonder, Amie L.
Hayman, Suzanne R.
Hobbs, Miriam A.
Gonsalves, Wilson I.
Hwa, Yi Lisa
Kapoor, Prashant
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Lin, Yi
Kourelis, Taxiarchis V.
Warsame, Rahma
Lust, John A.
Russell, Stephen J.
Zeldenrust, Steven R.
Kyle, Robert A.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Article History
Received: 13 November 2017
Revised: 3 January 2018
Accepted: 9 January 2018
First Online: 30 January 2018
Compliance with ethical standards
:
: AD: Celgene, Takeda, Pfizer, Prothena and Alnylam (research funding). MAG: Johnson and Johnson (honoraria). PK: Takeda, Amgen and Sanofi (research funding) and Celgene and Sanofi (consulting fees). YL: Janssen (research funding). SKK: Abbvie, Celgene, Janssen, Merck, Novartis, Roche, Sanofi, and Takeda (research funding) and Skyline Diagnostics (honoraria). The remaining authors declare that they have no conflict of interest.